Track topics on Twitter Track topics that are important to you
7577 West 103 Avenue Suite 212
United States of America
Phone: 303 410 6666
Fax: 303 410 6667
AMB-220-E is an international, multicenter, open-label study examining the long-term safety of ambrisentan (BSF 208075) in subjects who have previously completed Myogen study AMB-220, "A P...
Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. We believe that our adva...
Research and development of therapeutics based on signaling pathways in cardiac, hypertrophy, myosin heavy chain research and gene/protein expression profiling using its human cardiac tissue bank.
We have published hundreds of Myogen news stories on BioPortfolio along with dozens of Myogen Clinical Trials and PubMed Articles about Myogen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Myogen Companies in our database. You can also find out about relevant Myogen Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...